
Sign up to save your podcasts
Or
Dr. Shelley Hwang––BCRF investigator since 2016–– is an experienced clinical trialist with an interest in both the biology and treatment of early-stage breast cancer. In this episode, she discusses the urgent need to better understand Ductal Carcinoma in Situ (DCIS) and the work she and her team are doing to uncover better treatment options for patients with DCIS.
5
100100 ratings
Dr. Shelley Hwang––BCRF investigator since 2016–– is an experienced clinical trialist with an interest in both the biology and treatment of early-stage breast cancer. In this episode, she discusses the urgent need to better understand Ductal Carcinoma in Situ (DCIS) and the work she and her team are doing to uncover better treatment options for patients with DCIS.
65 Listeners
47 Listeners
7,926 Listeners
8,097 Listeners
52 Listeners
7 Listeners
23 Listeners
29,276 Listeners
1 Listeners
84 Listeners
39 Listeners
6 Listeners
19,745 Listeners
0 Listeners
109 Listeners